Member Since September 2024
Skills
About
Stacey Kennedy assumed the position of President, Americas Region and CEO of PMI’s U.S. business in January 2023. She is a member of PMI’s executive leadership team and an officer of the company. For the five years prior, Stacey served as President, South & Southeast Asia, PMI’s third-largest region by net revenue and the region with the company’s largest employee footprint. From July 2015 through 2017, she served as Managing Director, Germany, Austria, Croatia, and Slovenia, with Germany being one of PMI’s top four markets. From April 2013, Stacey was Area VP, Southeast Europe, responsible for 10 markets. Prior to these general management roles, she was the VP of Global Sales Strategy for PMI at its Operations Center in Lausanne, Switzerland. Earlier, Stacey served as VP, Sales for Altria Sales & Distribution Company Inc., servicing all of Altria Group, Inc.’s operating companies (Philip Morris USA, U.S. Smokeless Tobacco Company, and John Middleton Co.). She led a comprehensive sales system redesign to integrate the new acquisitions and support the sales force in selling Altria Group’s full portfolio of brands across multiple categories.
Stacey Kennedy
Company details
PMI's U.S. Business at Philip Morris International
Company bio
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. As of September 30, 2023, PMI's smoke-free products were available for sale in 82 markets, and PMI estimates that approximately 19.7 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products account for approximately 36.2% of PMI’s total third-quarter 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com.